Total views : 261

A Study on Skin Dose Changes with Changes in Body Weight From Tomotherapy for Head and Neck Cancer


  • Department of Radiological Science, Hanseo University, Korea, Republic of
  • Department of Proton Center, National Cancer Center, Korea, Republic of
  • Department of Health Administration, Dangjin Health City, Korea, Republic of
  • Department of Computer Engineering, Hanseo University, Korea, Republic of


Background/Objectives: When receiving radiation treatment in form of tomotherapy, most head and neck cancer patients show symptoms of weight loss caused by stomatitis and esophagitis, and skin burns. Weight loss may lead to a closer distance between the skin and the target, causing a change in the measured skin dose. This study was conducted to analyze such changes during the radiation treatment period. Methods/Statistical Analysis: The study also analyzed whether factors such as patient gender, age, diagnosis type, and treatment regimen, including surgery or chemotherapy in addition to radiotherapy, might influence the weight changes in patients, and collected values for changes in skin dose using thermoluminescence dosimeters. Findings: The study considered 20 patients with head and neck cancer, and all of these patients showed weight loss and an increase in measured skin dose. In addition, the gender or age of the patients had no direct relationship with their weight changes. Patients who hadn't undergone surgery prior to concurrent chemotherapy and radiation therapy showed a substantial weight loss. In comparison, the patients who had undergone surgery prior to concurrent chemotherapy and radiation therapy displayed the least amount of weight loss. As the amount of weight loss became larger, so did the skin dose that was measured during tomotherapy (p<.05). Application/Improvements: It appeared that greater weight loss led to an increase in measured skin dose, From this study, it is implied patients with large weight loss may benefit with an adjustment of their radiotherapy parameters while maintaining their target doses.


Chemotherapy, Thermoluminescence Dosimeter, Tomotherapy, Surgery, Weight Loss.

Full Text:

 |  (PDF views: 231)


  • Deng XW, Huang SM, Kron T, Metcalfe P. A Real-time in vivo dosimetry with MOSFET detectors in serial tomotherapy for head and neck cancer patients. Int. J. Radiation Oncology Biol. Phys. 2011 Aug; 80(5):1581–88.
  • Hani Alnawaf, Martin Butso. Measurement and effects of MOSKIN detectors on skin dose during high energy radiotherapy treatment. Australas Phys. Eng. Sci. Med. 2012 Sep; 35(3):321−28.
  • Rajesh A, Kinhikar K, Murthy V, Goel V. Dose measurements using MOSFET and TLD for head and neck patients treated with tomotherapy. Applied Radiation and Isotopes. 2009 Sep; 67(9):1683–85.
  • An-Cheng Shiau, Min-Chi Chiu, Tung-Ho Chen. Surface and superficial dose dosimetric verification for postmastectomy radiotherapy. Medical Dosimetry .2012 May; 37(4):417−24.
  • Gupta T, Mallik S, Master Z. Brain-sparing Holo-cranial Radiotherapy: a Unique Application of Helical Tomotherapy. Clinical Oncology. 2011 Mar; 23(2):86−94.
  • 6 Avanzo M, Drigo A, Roggio A. Dose to the skin in helical tomotherapy: Results of in vivo measurements with radiochromic films. Phys. Med. 2013 May; 29(3):304−11.
  • Harper JL, Lynette E. Skin Toxicity during Breast Irradiation: Pathophysiology and Management. Southern Medical Journal. 2004; 97(10):1−7.
  • Fiorino C, Pierelli A, Broqqi S. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiotherapy Oncology. 2006 Mar; 78(3):276−82.
  • Shima I, Parker BC, Hogstrom K, Fontenot J. Verification of calculated skin doses in postmastectomy helical tomotherapy. Int. J. Radiation Oncology Biol. Phys. 2011 Oct; 81(2):584−91.
  • Ki Chang Keum. Helical Tomotherapy: Image-guided Intensity Modulated Radiation Therapy. Journal of the Korean Medical Association. 2008 Jul; 51(7):619−29.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.